President Trump’s Proposed Budget Cuts to the National Institutes of Health

By Alexis Juergens for BioLawToday.org. President Trump released his preliminary 2018 budget plan on March 15th. While the budget plan proposes decreased federal funding in several areas, one of the agency’s receiving a cut in their budget is the National Institute of Health (“NIH”). The budget proposes to reduce NIH funding by 18%; this equates […]

Governing Digitally Integrated Genetic Resources

By Jorge Contreras for BiolawToday.org.  In a recent case, a French research institute agreed to share the benefits arising from a drug patent with an indigenous group in French Guinea. The French researchers had learned about the medicinal plant from members of the Kali’na, Palikur, and Creole communities, but failed to negotiate access and benefit sharing […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]

Contreras’ commentary in Science garners media coverage

Several media outlets covered new research published in Science by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras, which proposes universities holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   Contreras, along with […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]

Children’s School Lunches: Their History and Potential Future

By Alexis Juergens for BiolawToday.org. In 1946, Congress passed the National School Lunch Act. This act states that “It is hereby declared to be the policy of Congress, as a measure of national security to safeguard the health and well-being of the Nation’s children and to encourage the domestic consumption of nutritious agricultural commodities and other food, […]

First Major Revision to Common Rule for Human Subjects Research Released

On January 18, 2017, the Obama Administration finalized the first major overhaul of the so-called Common Rule for human subjects research which was first adopted in 1991.  The new rule applies to twenty different federal agencies funding research on human subjects, including the Department of Health and Human Services (which includes the National Institutes of […]

Sundance, philosophy and the law: S.J. Quinney College of Law Professor Leslie Francis will bring academic perspective to film festival

There’s a new correspondent reporting live from the Sundance Film Festival this year. Leslie Francis, a professor at the University of Utah S.J. Quinney College of Law, will be reporting from the festival from the lens of her academic expertise in law and philosophy. She’ll attend about 25 films at the festival from Jan.19-29, where […]

Law and Biomedicine Colloquium speaker Dave Gessel draws media attention

Dave Gessel, Executive Vice President at the Utah Hospital Association, participated in the Center for Law and Biomedicine Sciences (LABS) Colloquium speaker series on Wednesday, Jan. 18. Gessel discussed the future of healthcare with the forthcoming change in the U.S. presidency. A summary of what he said can be viewed in the following articles. Salt […]

MRI Machines and Patentability

By Steven Swan for BiolawToday.org. Here at the Center of Law and Biomedical Sciences, we are committed to addressing the ever-changing legal landscape in “areas of health policy, the life sciences, biotechnology, bioethics, and the medical and technological arts, in order to help overcome the most critical health-care challenges of our times.”[1] And at issue […]